American Society of Hematology

Figure 1.

$Figure 1. MT-I and MT-II expression in GCB, ACB, and type-3 subtypes of DLBCL. (A) MT-I and MT-II mRNA expression in 48 DLBCLs previously classified as GCB (n = 16), ABC (n = 23), and type-3 (n = 9) by expression profiling on Affymetrix arrays.15 For MT-I, the expression of 7 different isoforms represented on the Affymetrix 133A GeneChip is illustrated. C indicates complete remission; r, recurrent disease; and R, refractory disease. (B) MT-II mRNA expression values (arbitrary units) in the 3 different subtypes of DLBCL (GCB, ABC, type-3). CI indicates confidence interval.$

MT-I and MT-II expression in GCB, ACB, and type-3 subtypes of DLBCL. (A) MT-I and MT-II mRNA expression in 48 DLBCLs previously classified as GCB (n = 16), ABC (n = 23), and type-3 (n = 9) by expression profiling on Affymetrix arrays.¹⁵ For MT-I, the expression of 7 different isoforms represented on the Affymetrix 133A GeneChip is illustrated. C indicates complete remission; r, recurrent disease; and R, refractory disease. (B) MT-II mRNA expression values (arbitrary units) in the 3 different subtypes of DLBCL (GCB, ABC, type-3). CI indicates confidence interval.

This Feature Is Available To Subscribers Only